Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects (Q45145894)

10 December 2017

Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects (English)

1 reference

10 December 2017

0 references

1

Arne Astrup

1 reference

10 December 2017

Ian Caterson

2

1 reference

10 December 2017

Pierre Zelissen

3

1 reference

10 December 2017

Bernard Guy-Grand

4

1 reference

10 December 2017

Michele Carruba

5

1 reference

10 December 2017

Brian Levy

6

1 reference

10 December 2017

Xiang Sun

7

1 reference

10 December 2017

Martin Fitchet

8

1 reference

10 December 2017

1 October 2004

1 reference

10 December 2017

1 reference

10 December 2017

12

1 reference

10 December 2017

10

1 reference

10 December 2017

1658-1669

1 reference

The worldwide obesity epidemic

10 December 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Prevalence and Trends in Obesity Among US Adults, 1999-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Overweight as an avoidable cause of cancer in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Body mass index and the prevalence of hypertension and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Obesity and hypertension prevalence in populations of African origin. The Investigators of the International Collaborative Study on Hypertension in Blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

A prospective study of body mass index, weight change, and risk of stroke in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Influence of topiramate in the regulation of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Step-down multiple tests for comparing treatments with a control in unbalanced one-way layouts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Effect of topiramate on body weight and body composition of osborne-mendel rats fed a high-fat diet: alterations in hormones, neuropeptide, and uncoupling-protein mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

The continuing epidemics of obesity and diabetes in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Topiramate as an inhibitor of carbonic anhydrase isoenzymes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

Obesity and the environment: where do we go from here?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

The effects of topiramate and sex hormones on energy balance of male and female rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.206

31 March 2020

Identifiers

DOI

10.1038/OBY.2004.206

1 reference

10 December 2017

1 reference